BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16943682)

  • 1. Influence of endothelin-1 gene polymorphisms on the progression of autosomal dominant polycystic kidney disease.
    Reiterová J; Merta M; Stekrová J; Cabartová Z; Cibulka R; Maixnerová D; Rysavá R; Ríhová Z; Tesar V; Motán J
    Kidney Blood Press Res; 2006; 29(3):182-8. PubMed ID: 16943682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
    Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V
    Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of the endothelin-converting enzyme-1 gene polymorphism on the progression of autosomal dominant polycystic kidney disease.
    Reiterová J; Merta M; Stekrová J; Tesar V; Kmentová D; Ríhová Z; Rysavá R; Viklický O
    Ren Fail; 2006; 28(1):21-4. PubMed ID: 16526315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of G-protein beta3-subunit gene and endothelial nitric oxide synthase gene in exon 7 polymorphisms on progression of autosomal dominant polycystic kidney disease.
    Reiterová J; Miroslav M; Stekrová J; Kohoutová M; Tesar V; Kmentová D; Hubácek JA; Viklický O
    Ren Fail; 2004 Mar; 26(2):119-25. PubMed ID: 15287194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the alpha-adducin and ACE gene polymorphism on the progression of autosomal-dominant polycystic kidney disease.
    Merta M; Reiterová J; Stekrová J; Rysava R; Rihová Z; Tesar V; Viklický O; Kmentova D
    Kidney Blood Press Res; 2003; 26(1):42-9. PubMed ID: 12697976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of three endothelin-1 polymorphisms on the progression of IgA nephropathy.
    Maixnerová D; Merta M; Reiterová J; Stekrová J; Rysavá R; Obeidová H; Viklický O; Potmĕsil P; Tesar V
    Folia Biol (Praha); 2007; 53(1):27-32. PubMed ID: 17328840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifier effect of the Glu298Asp polymorphism of endothelial nitric oxide synthase gene in autosomal-dominant polycystic kidney disease.
    Stefanakis N; Ziroyiannis P; Trygonis S; Lamnissou K
    Nephron Clin Pract; 2008; 110(2):c101-6. PubMed ID: 18815450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis.
    Pereira TV; Nunes AC; Rudnicki M; Magistroni R; Albertazzi A; Pereira AC; Krieger JE
    Nephrol Dial Transplant; 2006 Nov; 21(11):3155-63. PubMed ID: 16935894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A promoter polymorphism of the alpha 8 integrin gene and the progression of autosomal-dominant polycystic kidney disease.
    Zeltner R; Hilgers KF; Schmieder RE; Porst M; Schulze BD; Hartner A
    Nephron Clin Pract; 2008; 108(3):c169-75. PubMed ID: 18277079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor polymorphism and autosomal dominant polycystic kidney disease.
    Magistroni R; Manfredini P; Furci L; Ligabue G; Martino C; Leonelli M; Scapoli C; Albertazzi A
    J Nephrol; 2003; 16(1):110-5. PubMed ID: 12653106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of candidate genes affecting the progression of renal disease in autosomal dominant polycystic kidney disease type 1.
    Tazón-Vega B; Vilardell M; Pérez-Oller L; Ars E; Ruiz P; Devuyst O; Lens X; Fernández-Llama P; Ballarín J; Torra R
    Nephrol Dial Transplant; 2007 Jun; 22(6):1567-77. PubMed ID: 17303584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease.
    Paterson AD; Magistroni R; He N; Wang K; Johnson A; Fain PR; Dicks E; Parfrey P; St George-Hyslop P; Pei Y
    J Am Soc Nephrol; 2005 Mar; 16(3):755-62. PubMed ID: 15677307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of ACE (I/D) and G460W polymorphism of alpha-adducin in autosomal dominant polycystic kidney disease.
    Persu A; El-Khattabi O; Messiaen T; Pirson Y; Chauveau D; Devuyst O
    Nephrol Dial Transplant; 2003 Oct; 18(10):2032-8. PubMed ID: 13679477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of endothelin 1 (G5665T and T-1370G) and endothelin receptor type A (C+70G and G-231A) in Graves' disease.
    Aydın AF; Develi-İş S; Doğru-Abbasoğlu S; Vural P; Ozderya A; Karadağ B; Uysal M
    Int Immunopharmacol; 2014 Jan; 18(1):198-202. PubMed ID: 24291390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the endothelin-1 gene locus for renal impairment in the general nondiabetic population.
    Pinto-Sietsma SJ; Herrmann SM; Schmidt-Petersen K; Niu T; Hillege HL; Janssen WM; de Zeeuw D; de Jong P; Kreutz R
    J Am Soc Nephrol; 2003 Oct; 14(10):2596-602. PubMed ID: 14514737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ENOS polymorphism is not associated with severity of renal disease in polycystic kidney disease 1.
    Walker D; Consugar M; Slezak J; Rossetti S; Torres VE; Winearls CG; Harris PC
    Am J Kidney Dis; 2003 Jan; 41(1):90-4. PubMed ID: 12500225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
    Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
    Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The angiotensin-converting enzyme insertion/deletion and the endothelin -134 3A/4A gene polymorphisms in patients with chronic plaque psoriasis.
    Weger W; Hofer A; Wolf P; El-Shabrawi Y; Renner W; Kerl H; Salmhofer W
    Exp Dermatol; 2007 Dec; 16(12):993-8. PubMed ID: 18031458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of colonic diverticular disease in autosomal dominant polycystic kidney disease without end-stage renal disease.
    Sharp CK; Zeligman BE; Johnson AM; Duley I; Gabow PA
    Am J Kidney Dis; 1999 Nov; 34(5):863-8. PubMed ID: 10561142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Polymorphisms in Endothelin-1 as Predictors for Long-Term Survival and the Cardiac Index in Patients Undergoing On-Pump Cardiac Surgery.
    Mansur A; Steinau M; Popov AF; Milenovic S; Bireta C; Weymann A; Schotola H; Wiese CH; Beissbarth T; Tzvetkov M; Hinz J
    PLoS One; 2015; 10(6):e0131155. PubMed ID: 26121692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.